Skip to content
Directory

Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
75
currently held
Exits tracked
18
hand-checked
Sectors covered
1
across the portfolio
Countries covered
12
from every market
92 companies matching · Page 1 of 2
DB
Dark Blue Therapeutics
Oxford Science Enterprises Balance Sheet
Exited 2026
BiotechUK· Entry 2020Oxford Science Enterprises
RG
ReNeuron Group
Obotritia Capital KGaA
Exited 2024
BiotechUnited KingdomObotritia Capital
PE
PetMedix
Parkwalk Opportunities EIS Fund
Exited 2023
BiotechUK· Entry 2019Parkwalk Advisors
UN
Univercells
AFB Fund I
Exited 2023
BiotechBelgiumAdBio Partners
DA
DJS Antibodies
LifeArc Ventures
Exited 2022
BiotechUK· Entry 2016LifeArc
DB
Ducentis BioTherapeutics
LifeArc Ventures
Exited 2022
BiotechUK· Entry 2019LifeArc
MI
MiroBio
Oxford Science Enterprises Balance Sheet
Exited 2022
BiotechUK· Entry 2019Oxford Science Enterprises
ET
eFFECTOR Therapeutics
Abingworth Bioventures VI
Exited 2021
BiotechUS· Entry 2013Abingworth
GT
Gyroscope Therapeutics
CIC Fund I
Exited 2021
BiotechUK· Entry 2019Cambridge Innovation Capital
OX
OXGENE
Mercia Direct Investments
Exited 2021
BiotechUK· Entry 2015Mercia Asset Management
CA
Calixar
Capital 2
Exited 2020
BiotechFrance· Entry 2012XAnge
IN
Integragen
FPCI Entreprise & Croissance I
Exited 2020
BiotechFrance· Entry 2010Generis Capital Partners
NA
The Native Antigen Company
Mercia Direct Investments
Exited 2020
BiotechUK· Entry 2014Mercia Asset Management
HY
Hybrigenics
Odyssee Venture Funds
Exited 2018
BiotechFrance· Entry 2013Odyssée Venture
AX
arGEN-X
Omnes Co-Investment
Exited 2017
BiotechNetherlands· Entry 2009Omnes Capital
HD
Horizon Discovery
Parkwalk Opportunities EIS Fund
Exited 2017
BiotechUK· Entry 2013Parkwalk Advisors
CE
Cellectis
Odyssee Venture Funds
Exited 2007
BiotechFrance· Entry 2002Odyssée Venture
AD
Adcendo
Jeito II
Active
BiotechDenmark· Entry 2026Jeito Capital
AB
Adicet Bio
Abingworth Bioventures VII
Active
BiotechUS· Entry 2021Abingworth
AD
AdvanCell
Abingworth Bioventures 8
Active
BiotechAustralia· Entry 2025Abingworth
AE
Aerska
Backed Fund III
Active
BiotechUK· Entry 2025BACKED VC
AT
Antares Therapeutics
Abingworth Bioventures 8
Active
BiotechUS· Entry 2025Abingworth
AT
Apini Therapeutics
Northern Gritstone Evergreen
Active
BiotechUK· Entry 2025Northern Gritstone
AA
Ascend Advanced Therapies
4BIO Ventures III
Active
BiotechUK· Entry 20234Bio Partners
AG
Ascend Gene & Cell Therapies
Abingworth Bioventures 8
Active
BiotechUK· Entry 2023Abingworth
AV
AviadoBio
LifeArc Ventures
Active
BiotechUK· Entry 2020LifeArc
AT
Axovia Therapeutics
ALSA Ventures European Biotechnology Fund
Active
BiotechUK· Entry 2023ALSA Ventures
BT
Bicycle Therapeutics
CIC Fund I
Active
BiotechUK· Entry 2016Cambridge Innovation Capital
BI
BioAscent
Maven Income and Growth VCT 4
Active
BiotechUK· Entry 2018Maven Capital Partners
BT
BiVictriX Therapeutics
Development Bank of Wales (Balance Sheet)
Active
BiotechUK· Entry 2016Development Bank of Wales
CA
CatalYm
Jeito I
Active
BiotechGermany· Entry 2022Jeito Capital
CB
Code Biotherapeutics
4BIO Ventures III
Active
BiotechUS· Entry 20224Bio Partners
CO
ConstructiveBio
Amadeus V Technology Fund
Active
BiotechUK· Entry 2022Amadeus Capital Partners
CB
Core Biogenesis
Digital 3
Active
BiotechFrance· Entry 2020XAnge
CT
CoSyne Therapeutics
Backed Fund II
Active
BiotechUK· Entry 2022BACKED VC
CT
Crucible Therapeutics
Northern Gritstone Evergreen
Active
BiotechUK· Entry 2023Northern Gritstone
CY
Cytosolix
Backed Fund III
Active
BiotechUSA· Entry 2023BACKED VC
CT
Cytospire Therapeutics
Abingworth Bioventures 8
Active
BiotechUK· Entry 2023Abingworth
DA
DaltonTx
IQ Capital Fund IV
Active
BiotechUK· Entry 2025IQ Capital Partners
DB
Dia Beta Labs
DSW Ventures
Active
BiotechUK· Entry 2024DSW Venture Capital
EB
Entact Bio
Abingworth Bioventures 8
Active
BiotechUS· Entry 2022Abingworth
EP
Epsilogen
ALSA Ventures European Biotechnology Fund
Active
BiotechUK· Entry 2018ALSA Ventures
ET
Etheros
Backed Fund III
Active
BiotechUK· Entry 2023BACKED VC
EX
Exapto
Generations powered by EDHEC
Active
BiotechFrance· Entry 2024Ring Capital
EX
Exicure
Abingworth Bioventures VI
Active
BiotechUS· Entry 2019Abingworth
FA
FabricNano
Backed Fund II
Active
BiotechUK· Entry 2019BACKED VC
GC
Glen Clova Scientific
DSW Ventures
Active
BiotechUK· Entry 2024DSW Venture Capital
GL
Glycomine
Abingworth Bioventures 8
Active
BiotechUS· Entry 2021Abingworth
HT
Hornet Therapeutics
4BIO Ventures III
Active
BiotechUK· Entry 20244Bio Partners
IK
Ikarovec
LifeArc Ventures
Active
BiotechUK· Entry 2020LifeArc
Previous12Next